Severin Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.11M Buy
926
+42
+5% +$42.9K 0.84% 28
2026
Q1
$813K Buy
884
+182
+26% +$185K 0.7% 41
2025
Q4
$755K Buy
702
+22
+3% +$21K 0.67% 41
2025
Q3
$519K Buy
680
+109
+19% +$81.1K 0.46% 79
2025
Q2
$445K Sell
571
-306
-35% -$238K 0.42% 101
2025
Q1
$724K Buy
877
+217
+33% +$181K 0.73% 30
2024
Q4
$509K Buy
+660
New +$546K 0.51% 68

Other funds holding LLY

Severin Investments's LLY Position: Q2 2026 in Review

Severin Investments increased its Eli Lilly (LLY) stake by 4.8% in Q2 2026, buying an estimated $42.9K and bringing the position to 926 shares worth $1.11M. The position accounts for 0.84% of the portfolio, ranked #28.

Severin Investments first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,594 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Severin Investments held 926 shares of Eli Lilly worth $1.11M as of Q2 2026.
  • Severin Investments bought 42 Eli Lilly shares in Q2 2026, an estimated $42.9K.
  • Eli Lilly made up 0.84% of Severin Investments's portfolio in Q2 2026, its #28 holding.
  • Severin Investments first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,594 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Severin Investments's 13F filing for Q2 2026, filed 14 Aug 2026.